REVB.L

Revolution Beauty Group plc
Revolution Beauty Gp - Related party transactions
23rd September 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 1320F
Revolution Beauty Group PLC
23 September 2024
 

For immediate release

23 September 2024

Revolution Beauty Group plc

("Revolution Beauty", the "Group", or the "Company")

Related party transactions

 

Revolution Beauty (AIM: REVB), announces that it has agreed to manufacture and supply beauty and personal care products via its manufacturing subsidiary, Revolution Beauty QB Ltd ("Revolution Labs"), for Carbon Theory Limited and Delhicious Ltd, companies in which Adam Minto has an equity interest (the "AM Companies").

The aggregate value of the revenue and profits before tax to be generated in the current financial year by Revolution Labs from sales to the AM Companies amounts to approximately £530,000 and £50,000, respectively. The pricing for the products to be sold have been agreed on an arm's length basis, benchmarked against similar transactions, with equivalent terms as other third party customers of Revolution Labs. The transactions will be settled in cash according to Revolution Labs' normal credit terms and details will be disclosed in the financial statements of the Group for the relevant period, being the current financial year.

The supply of products to the AM Companies constitute related party transactions under Rule 13 of the AIM Rules by virtue of the AM Companies being associates of Adam Minto, a substantial shareholder of Revolution Beauty, as defined in the AIM Rules, holding approximately 15.34% of the ordinary shares in the Company.  The directors of Revolution Beauty consider, having consulted with the Company's nominated adviser, Panmure Liberum Capital Limited, that the terms of the related party transactions are fair and reasonable insofar as shareholders of Revolution Beauty are concerned.

 

For further information, please contact:

 

Investor Relations

Lauren Brindley, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Panmure Liberum Capital Limited (NOMAD): Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

 

Zeus: Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

Media enquiries

Headland Consultancy: Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDGGDCCXDDGSG]]>
TwitterFacebookLinkedIn